within Pharmacolibrary.Drugs.C_CardiovascularSystem.C09A_AceInhibitorsPlain.C09AA05_Ramipril;

model Ramipril
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.44,
    Cl = 1.1666666666666668e-05,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.096,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.028333333333333332,
    Tlag = 10.200000000000001,
    Vdp = 0.591,
    k12 = 8.611111111111112e-06,
    k21 = 8.611111111111112e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Ramipril</td></tr><tr><td>ATC code:</td><td>C09AA05</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>96</td><td>L</td></tr>
    <tr><td>clearance:</td><td>42</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Ramipril is an angiotensin-converting enzyme (ACE) inhibitor used primarily for the treatment of hypertension, heart failure, and to reduce the risk of cardiovascular events in high-risk patients. It is an approved and widely used antihypertensive medication.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral dose administration.</p><h4>References</h4><ol><li><p>He, YL (2012). Clinical pharmacokinetics and pharmacodynamics of vildagliptin. <i>Clinical pharmacokinetics</i> 51(3) 147–162. DOI:<a href=\"https://doi.org/10.2165/11598080-000000000-00000\">10.2165/11598080-000000000-00000</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22339447/\">https://pubmed.ncbi.nlm.nih.gov/22339447</a></p></li><li><p>Russell, C, et al., &amp; Mohammed, AR (2015). Paediatric drug development of ramipril: reformulation, in vitro and in vivo evaluation. <i>Journal of drug targeting</i> 23(9) 854–863. DOI:<a href=\"https://doi.org/10.3109/1061186X.2015.1036275\">10.3109/1061186X.2015.1036275</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/25950602/\">https://pubmed.ncbi.nlm.nih.gov/25950602</a></p></li><li><p>Chatsiricharoenkul, S, et al., &amp; Kongpatanakul, S (2011). Bioequivalence study of 10 mg ramipril tablets in healthy Thai volunteers. <i>Journal of the Medical Association of Thailand = Chotmaihet thangphaet</i> 94(10) 1260–1266. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/22145513/\">https://pubmed.ncbi.nlm.nih.gov/22145513</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.C.C09AA05 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Ramipril;
